Preclinical Validation and Functional Assay Development
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract involves the preclinical validation of the transferrin receptor through a combination of in vitro and potential in vivo studies, focusing on functional assays to evaluate binding kinetics, cellular uptake efficiency, and molecular stability. The work is aimed at generating robust, standardized data packages that meet NIH requirements for downstream development, ensuring the target’s suitability for therapeutic applications. All deliverables must be comprehensive, reproducible, and formatted for regulatory submission. Performance is expected to be conducted with precision and scientific rigor, with the place of performance identified as Bethesda, Maryland, aligning with NIH’s research infrastructure. The opportunity is classified as a subcontract under NAICS code 541620, indicating it is for scientific research and development services. Proposals are due by July 31, 2026, and the posting date is July 24, 2026, indicating a tightly windowed submission process for qualified entities capable of delivering high-quality preclinical data under the oversight of the Department of Health and Human Services.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
